Radiotherapy outcomes in patients with interstitial lung disease and interstitial lung abnormalities: Adverse events and survival from a UK tertiary centre

Patients with ILD experience significantly worse survival and higher risk of adverse events, including fatal pneumonitis, following radiotherapy. ILA represents an intermediate-risk group. These findings highlight the need for improved pre-treatment identification and risk stratification using radiological and clinical tools, and highlights the importance of prospective validation in future studies.